Spiropent

Spiropent is a drug for the treatment of bronchial asthma and other respiratory diseases that are accompanied by bronchial obstruction. It belongs to the group of beta-adenemoimetic bronchodilators.

Injections, tablets and oral syrup contain clenbuterol hydrochloride as the active ingredient. The bronchodilation effect is due to a decrease in spasm of bronchial smooth muscles, hypersecretion of mucus and swelling of the mucous membrane of the respiratory tract. Restores breathing, reduces shortness of breath and improves the condition of patients within a few minutes after taking the drug. In chronic obstructive pulmonary diseases, it has an anti-inflammatory effect in